Fermentation Medium Optimization for Interferon Alpha 5 Purity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The production of interferon alpha 5 (IFNa5) in E. coli is hindered by the incorporation of an extra methionine residue at the N-terminal end and the generation of oxidized species, which complicates the purification process and reduces yield.

Innovation Solution

Controlling the concentration of microelements in the fermentation medium minimizes the incorporation of extra methionine and oxidized species, optimizing the production and purification of IFNa5 by using a carbon feed solution with specific microelement concentrations and a protease-deficient E. coli strain, followed by a chromatographic purification process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If IFNa5 is produced by expression in E. coli host cells using conventional fermentation methods, then large amounts of product can be obtained, but an extra methionine residue is incorporated at the N-terminal end and oxidized species are generated, complicating purification and reducing yield

Engineering Contradiction:
Improveproduction yield of IFNa5VSAvoidpurity of IFNa5 (minimizing extra methionine incorporation and oxidized species)
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by optimizing the fermentation medium composition, specifically controlling microelement concentrations (copper, zinc, manganese, calcium, iron) within defined ranges. This chemical parameter optimization prevents unwanted post-translational modifications (extra methionine incorporation and oxidation) while maintaining high productivity in E. coli expression systems

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements preliminary action by pre-optimizing the fermentation medium with specific microelement concentrations before protein expression occurs. This preventive approach ensures that the E. coli host cells are in the optimal physiological state to minimize unwanted modifications during IFNa5 production, thereby simplifying subsequent purification steps

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If conventional fermentation methods are used to produce IFNa5 in E. coli, then high cell densities can be achieved, but the purification process becomes more complex due to oxidized species and extra methionine residues

Engineering Contradiction:
Improveamount of IFNa5 producedVSAvoidcomplexity of purification process
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

By changing the chemical parameters of the fermentation medium (microelement concentrations), the patent reduces the formation of oxidized species and extra methionine residues, thereby simplifying the purification process while maintaining high production quantities

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If standard fermentation media are used for IFNa5 production, then the process is simple to operate, but extra methionine incorporation and oxidation occur, reducing production efficiency

Engineering Contradiction:
Improvesimplicity of fermentation processVSAvoidyield of therapeutically effective IFNa5
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent maintains ease of operation by using a defined fermentation medium with E. coli, but optimizes productivity by precisely controlling microelement concentrations. This approach achieves high yields of therapeutically effective IFNa5 while keeping the process relatively simple and scalable

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces the formation of oxidized methionilated and acetylated forms of IFNa5, increasing production yield and simplifying the purification process, resulting in a cost-effective and less complex method for producing therapeutically effective IFNa5.

Implementation Method 1

culturing the IFNa5 producing E. coli host cell under conditions effective to express said IFNa5 protein by said recombinant IFNa5 producing E. coli host cell in a fermentation medium

Methodology Applied
Scientific EffectFermentation: Fermentation

Implementation Method 2

the expressed IFNa5 protein is isolated and purified

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS8709757B2Method for producing interferon alpha 5
Publication Date: 2014.04.29 DIGNA BIOTECH
  • US8709757B2 patent drawing
  • US8709757B2 patent drawing
  • US8709757B2 patent drawing

AI summary

A process for producing an interferon alpha 5 (IFNa5) protein by expression in an IFNa5 producing Escherichia coli host cell, wherein incorporation of an extra methionine residue in the N-terminal end of the polypeptide chain is minimized as well as the generation of its oxidized species is disclosed. The IFNa5 protein can be purified by an efficient process to render a biologically active IFNa5.